🐜
|
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
24 auth.
K. Dijkstra,
C. M. Cattaneo,
F. Weeber,
M. Chalabi,
J. L. D. Haar,
Lorenzo F. Fanchi,
M. Slagter,
D. L. Velden,
S. Kaing,
S. Kelderman,
...
N. Rooij,
M. Leerdam,
A. Depla,
E. Smit,
K. Hartemink,
R. Groot,
M. Wolkers,
Norman Sachs,
P. Snaebjornsson,
K. Monkhorst,
J. Haanen,
H. Clevers,
T. Schumacher,
E. Voest
|
9 |
2018 |
9 🐜
|
🦁
|
Tumor organoid–T-cell coculture systems
9 auth.
C. M. Cattaneo,
K. Dijkstra,
Lorenzo F. Fanchi,
S. Kelderman,
S. Kaing,
N. Rooij,
...
S. Brink,
T. Schumacher,
E. Voest
|
7 |
2019 |
7 🦁
|
🐜
|
Werner helicase is a synthetic-lethal vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy and Immunotherapy.
24 auth.
G. Picco,
C. M. Cattaneo,
Esmée J. van Vliet,
G. Crisafulli,
G. Rospo,
Sarah Consonni,
S. Vieira,
Inigo Sanchez Rodriguez,
Carlotta Cancelliere,
R. Banerjee,
...
L. Schipper,
D. Oddo,
K. Dijkstra,
J. Cinatl,
M. Michaelis,
Fengtang Yang,
Cell Model Network Uk Group,
F. Di Nicolantonio,
A. Sartore-Bianchi,
S. Siena,
S. Arena,
E. Voest,
A. Bardelli,
M. Garnett
|
5 |
2021 |
5 🐜
|
🐜
|
Base editing screens map mutations affecting interferon-γ signaling in cancer
22 auth.
M. A. Coelho,
Sarah Cooper,
Magdalena E. Strauß,
E. Karakoç,
S. Bhosle,
E. Gonçalves,
G. Picco,
T. Burgold,
C. M. Cattaneo,
Vivien Veninga,
...
Sarah Consonni,
Cansu Dincer,
S. Vieira,
Freddy Gibson,
S. Barthorpe,
Claire W. Hardy,
Joel Rein,
Mark Thomas,
J. Marioni,
E. Voest,
Andrew R. Bassett,
M. Garnett
|
5 |
2023 |
5 🐜
|
🦁
|
Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens
11 auth.
C. M. Cattaneo,
Thomas W. Battaglia,
J. Urbanus,
Ziva Moravec,
Rhianne Voogd,
R. de Groot,
...
K. Hartemink,
J. Haanen,
E. Voest,
T. Schumacher,
W. Scheper
|
4 |
2023 |
4 🦁
|
🐜
|
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity.
27 auth.
C. Vennin,
C. M. Cattaneo,
Leontien Bosch,
S. Vegna,
Xuhui Ma,
Hugo G. J. Damstra,
Moreno Martinovic,
Efi Tsouri,
M. Ilić,
Leyla Azarang,
Jan R. T. van Weering,
Emilia M. Pulver,
Amber L. Zeeman,
T. Schelfhorst,
Jeroen O Lohuis,
...
A. Rios,
J. Dekkers,
L. Akkari,
R. Menezes,
R. Medema,
S. R. Baglio,
A. Akhmanova,
S. Linn,
S. Lemeer,
D. Pegtel,
E. Voest,
J. van Rheenen
|
4 |
2023 |
4 🐜
|
🐜
|
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
19 auth.
V. Amodio,
S. Lamba,
Rosaria Chilà,
C. M. Cattaneo,
Benedetta Mussolin,
G. Corti,
G. Rospo,
E. Berrino,
C. Tripodo,
F. Pisati,
...
A. Bartolini,
M. C. Aquilano,
S. Marsoni,
G. Mauri,
C. Marchiò,
S. Abrignani,
F. Di Nicolantonio,
G. Germano,
A. Bardelli
|
4 |
2022 |
4 🐜
|
🐬
|
Tumor Organoids as a Research Tool: How to Exploit Them
T. Booij,
C. M. Cattaneo,
C. Hirt
|
2 |
2022 |
2 🐬
|
🐜
|
Base editing screens define the genetic landscape of cancer drug resistance mechanisms
23 auth.
Matthew A. Coelho,
Magdalena E Strauss,
Alex Watterson,
Sarah Cooper,
S. Bhosle,
G. Illuzzi,
Emre Karakoc,
Cansu Dincer,
Sara F Vieira,
Mamta Sharma,
...
Marie Moullet,
Daniela Conticelli,
Jonas Koeppel,
Katrina McCarten,
C. M. Cattaneo,
Vivien Veninga,
Gabriele Picco,
Leopold Parts,
J. Forment,
E. Voest,
J. Marioni,
Andrew R. Bassett,
Mathew J. Garnett
|
2 |
2024 |
2 🐜
|
🦁
|
Identification of personalized cancer neoantigens with HANSolo
C. M. Cattaneo
|
1 |
2023 |
1 🦁
|